Skip to main content
. 2020 Jul 8;77(11):1–9. doi: 10.1001/jamapsychiatry.2020.1767

Table 2. Estimated Means (SE) and Significance of Temporal Changes for Sleep Diary Data.

Stage1 Mean (SE) Stage 2 Mean (SE)
Pretreatment (a) Posttreatment 1 (b) Change (b-a) P value Posttreatment 2 (c) Change (c-b) P value Follow-up
3 mo 6 mo 12 mo
Sleep onset latency, min
BT 42.2 (3.6) 21.1 (1.8) −21.1 (3.2) <.001 BT+ZOL 20.3 (1.9) −1.5 (2.6) .56 22.0 (3.0) 23.6 (3.2) 21.7 (3.2)
BT+CT 18.7 (2.5) −1.6 (2.6) .53 19.3 (1.8) 20.5 (2.4) 18.4 (2.1)
ZOL 41.6 (4.1) 29.9 (3.8) −11.7 (3.5) <.001 ZOL+BT 22.3 (4.1) −8.4 (4.5) .06 17.0 (2.6) 16.3 (2.4) 16.2 (2.0)
ZOL+trazodone 17.6 (4.5) −11.5 (6.4) .07 18.5 (3.0) 21.0 (3.3) 21.2 (3.3)
Wake after sleep onset, min
BT 60.6 (3.9) 27.6 (2.1) −33.0 (3.6) <.001 BT+ZOL 31.2 (5.3) 6.2 (5.2) .23 26.5 (3.7) 26.2 (3.2) 25.5 (3.2)
BT+CT 39.3 (4.5) 9.1 (4.3) .03 34.4 (3.9) 30.6 (3.7) 30.5 (3.7)
ZOL 59.4 (3.8) 42.8 (5.1) −16.6 (5.5) .003 ZOL+BT 31.2 (5.3) −10.5 (5.7) .06 29.7 (4.8) 28.9 (4.8) 32.7 (8.0)
ZOL+trazodone 32.0 (8.1) −11.9 (9.8) .22 20.9 (3.5) 22.0 (4.4) 19.2 (3.7)
Total sleep time, min
BT 360.4 (8.6) 370.9 (7.5) 10.6 (5.9) .07 BT+ZOL 356.3 (16.1) −9.6 (13.5) .48 398.4 (8.6) 404.7 (9.3) 414.9 (7.4)
BT+CT 371.4 (14.0) −4.7 (9.9) .64 400.8 (9.4) 401.0 (11.1) 407.4 (11.8)
ZOL 357.6 (9.6) 390.7 (12.2) 33.1 (11.7) .005 ZOL+BT 390.4 (16.7) 1.9 (17.0) .91 411.6 (12.1) 413.7 (11.1) 408.0 (11.7)
ZOL+trazodone 431.5 (19.8) 38.6 (23.6) .10 455.7 (8.3) 451.5 (12.4) 448.1 (10.1)
Sleep efficiency, %
BT 71.3 (1.4) 83.7 (0.9) 12.5 (1.1) <.001 BT+ZOL 81.5 (1.9) −2.1 (2.1) .32 83.9 (1.3) 84.5 (1.4) 85.7 (1.4)
BT+CT 81.8 (1.9) −2.1 (1.5) .14 84.2 (1.3) 81.9 (1.4) 85.4 (1.2)
ZOL 71.8 (1.4) 77.6 (2.2) 5.8 (1.8) .001 ZOL+BT 83.2 (1.9) 5.9 (2.6) .02 84.4 (1.8) 85.2 (1.6) 85.0 (1.8)
ZOL+trazodone 84.5 (3.0) 6.6 (4.1) .11 87.3 (1.3) 87.0 (1.4) 88.1 (1.2)

Abbreviations: BT, behavior therapy; CT, cognitive therapy; ZOL, zolpidem.